ChemBriefIndia's Cipla misses quarterly profit view on muted US sales
India's Cipla missed Q2 profit estimates as net earnings fell to 8.78 billion rupees due to weak US sales of generic Revlimid. While North American revenue declined 19%, Indian operations grew 12%, pa
reuters · 2026-10-27 00:58